Atul Mehta is a Respiratory physician affiliated with Cleveland Clinic. OpenAlex indexes 7 publications with 386 citations (h-index 4); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9500 Euclid Ave
Cleveland, OH 441950001
Telephone
800-223-2273Registry record last updated 6 Feb 2008.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- STERIS CORPORATIONProgram year20251 payment
- INTUITIVE SURGICAL, INC.Program year20241 payment
- Boston Scientific CorporationProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
23.2%Macrolide Antimicrobial12.4%Azithromycin100%Part D≥42 patientsShort-acting sulfonamides9%Sulfamethoxazole-Trimethoprim100%Part D≥37 patients+ 2 more classes in this area
Metabolism & gastrointestinal
23%Proton pump inhibitor9.8%Pantoprazole Sodium89%Omeprazole11%Part D<11 patientsCorticosteroid8.7%Prednisone100%Part D≥38 patients+ 3 more classes in this area
Respiratory
22%Corticosteroid11.1%Trelegy Ellipta34%Arnuity Ellipta27%Breo Ellipta18%Fluticasone Propionate14%Qvar Redihaler8%Part D<11 patientsLeukotriene Receptor Antagonist8.9%Montelukast Sodium100%Part D≥35 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Utility of EBUS-TBNA in Evaluating Mediastinal and Hilar Lymphadenopathy in Patients With Silica Exposure
Journal of Bronchology & Interventional Pulmonology
2025 - History of bronchoscopy: from inception to the modern era of interventional pulmonology
Current Opinion in Pulmonary Medicine
2025 - Rigid versus flexible bronchoscopy in interventional pulmonology: perspective from the master clinicians
Current Opinion in Pulmonary Medicine
2024 - Gone with the wind! Changes in the practice of bronchoscopy post pandemic
Annals of Thoracic Medicine
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Samir Kapadia, MD
Cleveland Clinic
Lars Svensson, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Gene Barnett, MD
Cleveland Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”